| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cellular component disassembly | 1.82e-05 | 617 | 29 | 7 | GO:0022411 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 4.72e-05 | 144 | 29 | 4 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 4.72e-05 | 144 | 29 | 4 | GO:0043244 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 4.86e-05 | 291 | 29 | 5 | GO:0032984 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translation | 8.53e-05 | 10 | 29 | 2 | GO:2000766 | |
| GeneOntologyBiologicalProcess | membrane protein intracellular domain proteolysis | 1.72e-04 | 14 | 29 | 2 | GO:0031293 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 3.69e-04 | 100 | 29 | 3 | GO:0043242 | |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 3.94e-04 | 21 | 29 | 2 | GO:1901386 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 4.25e-04 | 105 | 29 | 3 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 4.62e-04 | 108 | 29 | 3 | GO:0031110 | |
| GeneOntologyCellularComponent | dendritic branch | 3.89e-05 | 7 | 29 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 2.20e-04 | 85 | 29 | 3 | GO:0000118 | |
| Domain | Pept_M10A_Zn_BS | 2.09e-04 | 15 | 27 | 2 | IPR021158 | |
| Domain | PG_binding_1 | 3.76e-04 | 20 | 27 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 3.76e-04 | 20 | 27 | 2 | IPR002477 | |
| Domain | Pept_M10A | 5.00e-04 | 23 | 27 | 2 | IPR021190 | |
| Domain | M10A_MMP | 5.00e-04 | 23 | 27 | 2 | IPR033739 | |
| Domain | Peptidase_M10 | 5.45e-04 | 24 | 27 | 2 | PF00413 | |
| Domain | ZnMc | 7.98e-04 | 29 | 27 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 7.98e-04 | 29 | 27 | 2 | IPR006026 | |
| Domain | CYSTEINE_SWITCH | 1.59e-03 | 41 | 27 | 2 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 1.75e-03 | 43 | 27 | 2 | IPR001818 | |
| Domain | RhoGAP | 3.61e-03 | 62 | 27 | 2 | SM00324 | |
| Domain | RhoGAP | 3.72e-03 | 63 | 27 | 2 | PF00620 | |
| Domain | RHOGAP | 3.84e-03 | 64 | 27 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 3.84e-03 | 64 | 27 | 2 | IPR000198 | |
| Domain | - | 3.84e-03 | 64 | 27 | 2 | 1.10.555.10 | |
| Domain | CH | 3.96e-03 | 65 | 27 | 2 | SM00033 | |
| Domain | CH | 4.57e-03 | 70 | 27 | 2 | PF00307 | |
| Domain | - | 4.70e-03 | 71 | 27 | 2 | 1.10.418.10 | |
| Domain | CH | 4.96e-03 | 73 | 27 | 2 | PS50021 | |
| Domain | CH-domain | 5.23e-03 | 75 | 27 | 2 | IPR001715 | |
| Domain | MetalloPept_cat_dom | 6.08e-03 | 81 | 27 | 2 | IPR024079 | |
| Domain | - | 6.08e-03 | 81 | 27 | 2 | 3.40.390.10 | |
| Domain | Rho_GTPase_activation_prot | 7.14e-03 | 88 | 27 | 2 | IPR008936 | |
| Domain | ZINC_PROTEASE | 8.78e-03 | 98 | 27 | 2 | PS00142 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 3.01e-04 | 439 | 20 | 5 | MM15595 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 3.38e-04 | 450 | 20 | 5 | M27078 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 7.59e-04 | 29 | 20 | 2 | MM15981 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 8.12e-04 | 30 | 20 | 2 | M39652 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 9.83e-04 | 33 | 20 | 2 | M26976 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.01e-03 | 142 | 20 | 3 | MM15576 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.16e-03 | 149 | 20 | 3 | M41805 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 1.30e-03 | 38 | 20 | 2 | MM14611 | |
| Pathway | WP_OVARIAN_INFERTILITY | 1.37e-03 | 39 | 20 | 2 | M39458 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 1.77e-03 | 649 | 20 | 5 | MM15690 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 1.91e-03 | 46 | 20 | 2 | M46450 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.99e-03 | 47 | 20 | 2 | M29777 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.25e-03 | 50 | 20 | 2 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.52e-03 | 53 | 20 | 2 | MM14566 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 2.80e-03 | 720 | 20 | 5 | M41838 | |
| Pathway | WP_11P112_COPY_NUMBER_VARIATION_SYNDROME | 2.81e-03 | 56 | 20 | 2 | M48075 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 3.01e-03 | 58 | 20 | 2 | MM15602 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 3.12e-03 | 59 | 20 | 2 | M41812 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.33e-03 | 61 | 20 | 2 | M27103 | |
| Pathway | PID_AR_PATHWAY | 3.33e-03 | 61 | 20 | 2 | M58 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.66e-03 | 64 | 20 | 2 | M26953 | |
| Pathway | WP_AGERAGE_PATHWAY | 3.88e-03 | 66 | 20 | 2 | M39420 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 5.12e-03 | 76 | 20 | 2 | MM14573 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 24755685 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 24615104 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 37312734 | ||
| Pubmed | Poly(ADP-ribose) glycohydrolase is a component of the FMRP-associated messenger ribonucleoparticles. | 6.71e-07 | 2 | 29 | 2 | 16117724 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 21273427 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 25607396 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 18308831 | ||
| Pubmed | A deregulated immune response to gliadin causes a decreased villus height in DQ8 transgenic mice. | 6.70e-06 | 5 | 29 | 2 | 19795413 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 20827277 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 17373931 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 18006768 | ||
| Pubmed | Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice. | 1.41e-05 | 7 | 29 | 2 | 26163370 | |
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 10731089 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 17607721 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 25770908 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 16356191 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 15755524 | ||
| Pubmed | Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. | 2.41e-05 | 9 | 29 | 2 | 10986281 | |
| Pubmed | TGF-beta3-induced palatogenesis requires matrix metalloproteinases. | 3.68e-05 | 11 | 29 | 2 | 11359935 | |
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 37312667 | ||
| Pubmed | 5.21e-05 | 13 | 29 | 2 | 12815621 | ||
| Pubmed | 6.07e-05 | 14 | 29 | 2 | 25636537 | ||
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 22810622 | ||
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 20484597 | ||
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 10949577 | ||
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 37701782 | ||
| Pubmed | Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases. | 9.06e-05 | 17 | 29 | 2 | 27398409 | |
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 1.53e-04 | 22 | 29 | 2 | 23421805 | |
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 10419448 | ||
| Pubmed | 1.83e-04 | 24 | 29 | 2 | 15734845 | ||
| Pubmed | 2.72e-04 | 1116 | 29 | 6 | 31753913 | ||
| Pubmed | 4.16e-04 | 36 | 29 | 2 | 20587546 | ||
| Pubmed | Identification of UHRF1/2 as new N-methylpurine DNA glycosylase-interacting proteins. | 4.63e-04 | 38 | 29 | 2 | 23537643 | |
| Pubmed | 5.93e-04 | 43 | 29 | 2 | 36950384 | ||
| Pubmed | 6.21e-04 | 44 | 29 | 2 | 35493520 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 6.22e-04 | 475 | 29 | 4 | 31040226 | |
| Pubmed | Opposing LSD1 complexes function in developmental gene activation and repression programmes. | 6.79e-04 | 46 | 29 | 2 | 17392792 | |
| Pubmed | 7.37e-04 | 497 | 29 | 4 | 23414517 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 7.37e-04 | 497 | 29 | 4 | 36774506 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 2.10e-03 | 107 | 29 | 2 | chr11q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 3.40e-03 | 137 | 29 | 2 | chr1p35 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 2.85e-04 | 24 | 19 | 2 | 891 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.24e-03 | 50 | 19 | 2 | 721 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 2.92e-06 | 856 | 29 | 8 | M4500 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.03e-05 | 466 | 29 | 6 | M13522 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.80e-05 | 300 | 29 | 5 | M8702 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN | 6.60e-05 | 199 | 29 | 4 | M4567 | |
| Coexpression | GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN | 6.73e-05 | 200 | 29 | 4 | M391 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP | 6.73e-05 | 200 | 29 | 4 | M3962 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.44e-06 | 171 | 29 | 4 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-06 | 199 | 29 | 4 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-06 | 199 | 29 | 4 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.19e-05 | 22 | 29 | 2 | 5e0e18cc2c48d76212285e0d58cfb3047f5239de | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.71e-04 | 167 | 29 | 3 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.74e-04 | 168 | 29 | 3 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.74e-04 | 168 | 29 | 3 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 171 | 29 | 3 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.90e-04 | 173 | 29 | 3 | 2e9dc137f3675eee07f941eb4cfcaf24a83ab0fb | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 176 | 29 | 3 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 178 | 29 | 3 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.17e-04 | 181 | 29 | 3 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 181 | 29 | 3 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 181 | 29 | 3 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 181 | 29 | 3 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-04 | 186 | 29 | 3 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-04 | 186 | 29 | 3 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 2.38e-04 | 187 | 29 | 3 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-04 | 187 | 29 | 3 | 8ee3bf885897efd634c3a0567637142a9f55e693 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 2.42e-04 | 188 | 29 | 3 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.46e-04 | 189 | 29 | 3 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.50e-04 | 190 | 29 | 3 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.50e-04 | 190 | 29 | 3 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-04 | 192 | 29 | 3 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.58e-04 | 192 | 29 | 3 | 61677831b096b36f6325e9cb047483dd72aa71c2 | |
| ToppCell | wk_15-18|World / Celltypes from embryonic and fetal-stage human lung | 2.62e-04 | 193 | 29 | 3 | a28ff1e80e3e741739abe869df5fbd41352a1ea0 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.62e-04 | 193 | 29 | 3 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.66e-04 | 194 | 29 | 3 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.66e-04 | 194 | 29 | 3 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.66e-04 | 194 | 29 | 3 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 2.70e-04 | 195 | 29 | 3 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.70e-04 | 195 | 29 | 3 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.74e-04 | 196 | 29 | 3 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 196 | 29 | 3 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-04 | 197 | 29 | 3 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.78e-04 | 197 | 29 | 3 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.78e-04 | 197 | 29 | 3 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-04 | 197 | 29 | 3 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.78e-04 | 197 | 29 | 3 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-04 | 197 | 29 | 3 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.78e-04 | 197 | 29 | 3 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.82e-04 | 198 | 29 | 3 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-04 | 198 | 29 | 3 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.86e-04 | 199 | 29 | 3 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.86e-04 | 199 | 29 | 3 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.90e-04 | 200 | 29 | 3 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.90e-04 | 200 | 29 | 3 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.90e-04 | 200 | 29 | 3 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.90e-04 | 200 | 29 | 3 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| Computational | Genes in the cancer module 211. | 1.28e-04 | 11 | 17 | 2 | MODULE_211 | |
| Computational | MMPs. | 4.86e-04 | 21 | 17 | 2 | MODULE_562 | |
| Computational | Genes in the cancer module 210. | 8.69e-04 | 28 | 17 | 2 | MODULE_210 | |
| Disease | matrix metalloproteinase 7 measurement | 2.60e-05 | 8 | 29 | 2 | EFO_0010591 | |
| Disease | platelet crit | 2.16e-03 | 952 | 29 | 5 | EFO_0007985 | |
| Disease | gastroesophageal reflux disease | 4.43e-03 | 101 | 29 | 2 | EFO_0003948 | |
| Disease | fibrinogen measurement | 5.14e-03 | 109 | 29 | 2 | EFO_0004623 | |
| Disease | lower face morphology measurement | 5.14e-03 | 109 | 29 | 2 | EFO_0010948 | |
| Disease | S-7-hydroxywarfarin measurement | 5.24e-03 | 110 | 29 | 2 | EFO_0803329 | |
| Disease | endometrial carcinoma | 5.52e-03 | 113 | 29 | 2 | EFO_1001512 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSSQSHESFSDWRGE | 3011 | Q99996 | |
| DDHWALDGHVSSESS | 3351 | Q7Z408 | |
| DSVDWHSDDEPSLGR | 186 | Q96Q83 | |
| DSQGHSEDSERWSGS | 626 | P20930 | |
| SEDSERWSGSASRNH | 631 | P20930 | |
| DSEGHSEDSERWSGS | 951 | P20930 | |
| SEDSERWSGSASRNH | 956 | P20930 | |
| DSDSQGHSEDSERWS | 1921 | P20930 | |
| GHSEDSERWSGSASR | 1926 | P20930 | |
| SDSQGHSEDSERWSG | 2571 | P20930 | |
| HSEDSERWSGSASRN | 2576 | P20930 | |
| DSEGHSEDSERWSGS | 2896 | P20930 | |
| SEDSERWSGSASRNH | 2901 | P20930 | |
| SEGHSEDSERWSGSA | 3221 | P20930 | |
| SWEEGSSGSSSDEEH | 86 | Q9UKL0 | |
| EDHCRRSWSSDSTDS | 51 | P55040 | |
| HFDEDERWTDGSSLG | 191 | P09237 | |
| DDDQHWSDSPSDADR | 1101 | Q7RTP6 | |
| SGRSHWDDSTSDSEL | 2096 | P78559 | |
| GGDAHFDDDETWTSS | 196 | P45452 | |
| WSRSHEDGSERDDWQ | 801 | Q86W56 | |
| HDVTVDADSWDDSSS | 871 | Q8IVL0 | |
| QSADTSWRAHADDEL | 46 | P48681 | |
| LSSHDGSESSFEWSD | 1456 | O60449 | |
| GSASESEHRSWARES | 916 | P48552 | |
| VSASDADEAGSDHAW | 561 | Q6V1P9 | |
| DDSDWTVTADGSHHA | 4476 | Q5VST9 | |
| SHRTSAWLDDGDELD | 711 | O14559 | |
| ETESDHRDELSDWSL | 501 | Q06787 | |
| SAADGSDGSHDSWDV | 21 | Q9Y4C1 | |
| SDGSHDSWDVERVAE | 26 | Q9Y4C1 | |
| ADSAHWEDARSSGGT | 71 | A1L168 | |
| DRSDSSEGWSDAHLD | 596 | Q8IUH8 | |
| WEAVEVGASSHDSDE | 41 | P0DL12 | |
| SDGDKDSRWHLSEDE | 391 | Q96BR9 | |
| DLSDEDAGWRTSLSE | 121 | Q4G0A6 | |
| TSEEEERAWHSDGSS | 831 | Q8WWQ0 | |
| TDGSLDSWGTSEDAD | 656 | Q9P227 | |
| SSDRDLWAPAADTHE | 51 | Q15904 | |
| LRGESAADSDGWDSA | 66 | Q9BUL5 |